Moderna to Host Investor Event – R&D Day and Business Updates

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / August 30, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor…

NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023

2 years ago

WOBURN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the…

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer

2 years ago

AUSTIN, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. announced today completion of enrollment of the Phase II portion…

Stress Affects Sex. Male Plus Can Help.

2 years ago

The Natural Libido Enhancer Includes Ginseng as a Way to Reduce Stress.Fort Lauderdale, FL, Aug. 30, 2023 (GLOBE NEWSWIRE) --…

Male Plus Uses Maca to Naturally Enhance Intercourse

2 years ago

The Brand’s Signature Product Uses a Combination of Natural Active Ingredients, Including the Essential Addition of MacaFort Lauderdale, FL, Aug.…

Editas Medicine Announces Upcoming Investor Events

2 years ago

CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced…

Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment

2 years ago

ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

Annual Results – Momentum Building on our Commercial Plans

2 years ago

MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader…

Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars

2 years ago

FDA clearance supported by a clinical study (n=67) and demonstrated treatment safety and efficacy utilizing SUPERB™, 97% of the treated…

Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023

2 years ago

MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing…